Apnimed, Inc.

US$15.10As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:APMDHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM 1.778
TSR TTM —
Mkt cap US$628.6M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$19
24.98%
(44.86%)
Hold 4|3|2|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.19
0.20
0.20
0.20
2.87%
(1.78%)
4.12%
2.56%
Revenue$M
41.50
42.61
44.64
44.98
5.69%
7.37%
14.28%
14.18%
Peers (US$628.6M)
Cap (US$)
PE
637.7M
—
Capital
TTM
5Y
10Y
Leveragex
3.677
0.172
0.202
EBIT/Intx
2.211
0.205
0.200
Own earn%
93.22
(99.86)
(67.63)
Sh yield%
49.84
54.09
54.20
Owners
Insiders/Inst%
3.87
58.09
Short interest%
4.86
SBC / revenue%
2.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
16–25
$1 testx
0.0
Incr. ROIC%
4